| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 875.69% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/12/2023 | 875.69% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
| 10/13/2022 | 1119.61% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
What is the target price for Imunon (IMNN)?
The latest price target for Imunon (NASDAQ: IMNN) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $12.00 expecting IMNN to rise to within 12 months (a possible 875.69% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Imunon (IMNN)?
The latest analyst rating for Imunon (NASDAQ: IMNN) was provided by HC Wainwright & Co., and Imunon reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Imunon (IMNN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imunon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imunon was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Imunon (IMNN) correct?
While ratings are subjective and will change, the latest Imunon (IMNN) rating was a reiterated with a price target of $0.00 to $12.00. The current price Imunon (IMNN) is trading at is $1.23, which is within the analyst's predicted range.